Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

An Early Progress Report

An Early Progress Report Editorial ow that the first three issues of our new journal have been published, an early assessment of our progress seems in order. Response from the arteriosclerosis research community to the content, style, and format of the journal has been encouraging. The editors believe that we are close to achieving our goal of a truly interdisciplinary journal in the field, but we need an increased variety of submissions to achieve a still better balance. In particular, we would like to receive more manuscripts in the areas of thrombosis, biochemistry of the arterial wall, and population studies. The Editorial Board has been actively involved, and scientists from a wide spectrum of the research community have been generous in acting as reviewers. The initial data (to April 15) are very reassuring. We are in the excellent position of offering rapid review and publication while maintaining high quality content. The noteworthy statistics include: Average time for reviews 29 days Average time from receipt of a manuscript to the first editorial decision 43 days Average number of months from receipt of a manuscript to publication 5.5 months Percentage of manuscripts accepted 43% Average reviewer priority for accepted manuscripts (on a scale of 1 to 5) 2.3 In view of these encouraging statistics, we expect to maintain a con- tinuous flow of accepted papers that will meet our publication deadlines and ensure early mailing of future issues. Our rapid publication rate of high quality manuscripts should add to the attractiveness of this journal when choices are being made regarding manuscript submission. We hope that you share our enthusiasm for Arteriosclerosis: A Journal of Vascular Biology and Disease, and agree with the Editors that it is well on the way toward becoming the journal that is the standard of excellence in the field of arteriosclerosis research. Edwin L. Bierman, Editor http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Arteriosclerosis Wolters Kluwer Health

An Early Progress Report

Bierman, Edwin L.
Arteriosclerosis , Volume 1 (3) – May 1, 1981
Download PDF
1 page

Loading next page...
 
/lp/wolters-kluwer-health/an-early-progress-report-l4B4M0LsOW

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Copyright
© 1981 by American Heart Association, Inc.
ISSN
0276-5047

Abstract

Editorial ow that the first three issues of our new journal have been published, an early assessment of our progress seems in order. Response from the arteriosclerosis research community to the content, style, and format of the journal has been encouraging. The editors believe that we are close to achieving our goal of a truly interdisciplinary journal in the field, but we need an increased variety of submissions to achieve a still better balance. In particular, we would like to receive more manuscripts in the areas of thrombosis, biochemistry of the arterial wall, and population studies. The Editorial Board has been actively involved, and scientists from a wide spectrum of the research community have been generous in acting as reviewers. The initial data (to April 15) are very reassuring. We are in the excellent position of offering rapid review and publication while maintaining high quality content. The noteworthy statistics include: Average time for reviews 29 days Average time from receipt of a manuscript to the first editorial decision 43 days Average number of months from receipt of a manuscript to publication 5.5 months Percentage of manuscripts accepted 43% Average reviewer priority for accepted manuscripts (on a scale of 1 to 5) 2.3 In view of these encouraging statistics, we expect to maintain a con- tinuous flow of accepted papers that will meet our publication deadlines and ensure early mailing of future issues. Our rapid publication rate of high quality manuscripts should add to the attractiveness of this journal when choices are being made regarding manuscript submission. We hope that you share our enthusiasm for Arteriosclerosis: A Journal of Vascular Biology and Disease, and agree with the Editors that it is well on the way toward becoming the journal that is the standard of excellence in the field of arteriosclerosis research. Edwin L. Bierman, Editor

Journal

Arteriosclerosis – Wolters Kluwer Health

Published: May 1, 1981

There are no references for this article.